DSFIR Intrinsic Valuation and Fundamental Analysis - DSM-Firmenich AG - Alpha Spread
D

DSM-Firmenich AG
AEX:DSFIR

Watchlist Manager
DSM-Firmenich AG
AEX:DSFIR
Watchlist
Price: 116.6 EUR 0.52% Market Closed
Market Cap: 31B EUR
Have any thoughts about
DSM-Firmenich AG?
Write Note

Intrinsic Value

The intrinsic value of one DSFIR stock under the Base Case scenario is 100.02 EUR. Compared to the current market price of 116.6 EUR, DSM-Firmenich AG is Overvalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DSFIR Intrinsic Value
100.02 EUR
Overvaluation 14%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
DSM-Firmenich AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DSFIR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DSFIR?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about DSM-Firmenich AG

Provide an overview of the primary business activities
of DSM-Firmenich AG.

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DSM-Firmenich AG.

Provide P/S
for DSM-Firmenich AG.

Provide P/E
for DSM-Firmenich AG.

Provide P/OCF
for DSM-Firmenich AG.

Provide P/FCFE
for DSM-Firmenich AG.

Provide P/B
for DSM-Firmenich AG.

Provide EV/S
for DSM-Firmenich AG.

Provide EV/GP
for DSM-Firmenich AG.

Provide EV/EBITDA
for DSM-Firmenich AG.

Provide EV/EBIT
for DSM-Firmenich AG.

Provide EV/OCF
for DSM-Firmenich AG.

Provide EV/FCFF
for DSM-Firmenich AG.

Provide EV/IC
for DSM-Firmenich AG.

Show me price targets
for DSM-Firmenich AG made by professional analysts.

What are the Revenue projections
for DSM-Firmenich AG?

How accurate were the past Revenue estimates
for DSM-Firmenich AG?

What are the Net Income projections
for DSM-Firmenich AG?

How accurate were the past Net Income estimates
for DSM-Firmenich AG?

What are the EPS projections
for DSM-Firmenich AG?

How accurate were the past EPS estimates
for DSM-Firmenich AG?

What are the EBIT projections
for DSM-Firmenich AG?

How accurate were the past EBIT estimates
for DSM-Firmenich AG?

Compare the revenue forecasts
for DSM-Firmenich AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DSM-Firmenich AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DSM-Firmenich AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of DSM-Firmenich AG compared to its peers.

Compare the P/E ratios
of DSM-Firmenich AG against its peers.

Discuss the investment returns and shareholder value creation
comparing DSM-Firmenich AG with its peers.

Analyze the financial leverage
of DSM-Firmenich AG compared to its main competitors.

Show all profitability ratios
for DSM-Firmenich AG.

Provide ROE
for DSM-Firmenich AG.

Provide ROA
for DSM-Firmenich AG.

Provide ROIC
for DSM-Firmenich AG.

Provide ROCE
for DSM-Firmenich AG.

Provide Gross Margin
for DSM-Firmenich AG.

Provide Operating Margin
for DSM-Firmenich AG.

Provide Net Margin
for DSM-Firmenich AG.

Provide FCF Margin
for DSM-Firmenich AG.

Show all solvency ratios
for DSM-Firmenich AG.

Provide D/E Ratio
for DSM-Firmenich AG.

Provide D/A Ratio
for DSM-Firmenich AG.

Provide Interest Coverage Ratio
for DSM-Firmenich AG.

Provide Altman Z-Score Ratio
for DSM-Firmenich AG.

Provide Quick Ratio
for DSM-Firmenich AG.

Provide Current Ratio
for DSM-Firmenich AG.

Provide Cash Ratio
for DSM-Firmenich AG.

What is the historical Revenue growth
over the last 5 years for DSM-Firmenich AG?

What is the historical Net Income growth
over the last 5 years for DSM-Firmenich AG?

What is the current Free Cash Flow
of DSM-Firmenich AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for DSM-Firmenich AG.

Business Breakdown

DSM-Firmenich AG is a global leader in the nutrition, health, and beauty sectors, born from the merger of Dutch multinational DSM and Swiss flavor and fragrance company Firmenich. This innovative company specializes in creating sustainable solutions, leveraging science and technology to enhance the quality of life across a diverse range of industries, including food, beverages, personal care, and pharmaceuticals. With a robust portfolio of products aimed at enriching human and environmental health, DSM-Firmenich aims to meet the growing consumer demand for healthier, more sustainable options. Their commitment to sustainability positions them favorably within the markets they serve, as consum...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
DSM-Firmenich AG

Balance Sheet Decomposition
DSM-Firmenich AG

Current Assets 10.3B
Cash & Short-Term Investments 3.4B
Receivables 3.1B
Other Current Assets 3.9B
Non-Current Assets 24.8B
Long-Term Investments 965m
PP&E 5.3B
Intangibles 18.4B
Other Non-Current Assets 135m
Current Liabilities 4.8B
Accounts Payable 2.1B
Other Current Liabilities 2.7B
Non-Current Liabilities 7.3B
Long-Term Debt 4.1B
Other Non-Current Liabilities 3.2B
Efficiency

Earnings Waterfall
DSM-Firmenich AG

Revenue
10.6B EUR
Cost of Revenue
-8B EUR
Gross Profit
2.6B EUR
Operating Expenses
-3.1B EUR
Operating Income
-442m EUR
Other Expenses
2.6B EUR
Net Income
2.1B EUR

Free Cash Flow Analysis
DSM-Firmenich AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DSFIR Profitability Score
Profitability Due Diligence

DSM-Firmenich AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive Free Cash Flow
Positive ROE
46/100
Profitability
Score

DSM-Firmenich AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

DSFIR Solvency Score
Solvency Due Diligence

DSM-Firmenich AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
50/100
Solvency
Score

DSM-Firmenich AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DSFIR Price Targets Summary
DSM-Firmenich AG

Wall Street analysts forecast DSFIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSFIR is 128.25 EUR with a low forecast of 90.9 EUR and a high forecast of 165.9 EUR.

Lowest
Price Target
90.9 EUR
22% Downside
Average
Price Target
128.25 EUR
10% Upside
Highest
Price Target
165.9 EUR
42% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DSFIR?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for DSFIR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about DSFIR dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

DSFIR Price
DSM-Firmenich AG

1M 1M
-2%
6M 6M
+10%
1Y 1Y
+45%
3Y 3Y
+1%
5Y 5Y
+1%
10Y 10Y
+1%
Annual Price Range
116.6
52w Low
76.13
52w High
123.2
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -36%
Shares Statistics
Market Capitalization 31B EUR
Shares Outstanding 265 800 000
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

DSM-Firmenich AG

Country

Switzerland

Industry

Chemicals

Market Cap

31B EUR

Dividend Yield

2.09%

Description

DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.

Contact

AARGAU
Wurmisweg 576, Kaiseraugst

IPO

2023-04-18

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one DSFIR stock?

The intrinsic value of one DSFIR stock under the Base Case scenario is 100.02 EUR.

Is DSFIR stock undervalued or overvalued?

Compared to the current market price of 116.6 EUR, DSM-Firmenich AG is Overvalued by 14%.

Back to Top